Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.31B
Revenue (ttm)	886.92M
Net Income (ttm)	76.52M
Shares Out	961.94M
EPS (ttm)	0.08
PE Ratio	17.09
Forward PE	13.99
Dividend	0.03 (2.19%)
Ex-Dividend Date	Sep 8, 2025

Volume	254,900
Average Volume	799,225
Open	1.350
Previous Close	1.345
Day's Range	1.350 - 1.370
52-Week Range	1.070 - 1.460
Beta	0.36
RSI	57.19
Earnings Date	Aug 15, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.